These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2827913)

  • 1. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.
    Foult JM; Tavolaro O; Antony I; Nitenberg A
    Circulation; 1988 Feb; 77(2):337-44. PubMed ID: 2827913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilation induced by intracoronary enalaprilat: an argument for the role of a local renin-angiotensin system in patients with dilated cardiomyopathy.
    Foult JM; Tavolaro O; Antony I; Nitenberg A
    Eur Heart J; 1989 Nov; 10 Suppl F():97-100. PubMed ID: 2559850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
    Friedrich SP; Lorell BH; Rousseau MF; Hayashida W; Hess OM; Douglas PS; Gordon S; Keighley CS; Benedict C; Krayenbuehl HP
    Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy.
    Mohri M; Tagawa H; Egashira K; Takeshita A
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):249-55. PubMed ID: 10672857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy.
    Kyriakidis M; Triposkiadis F; Dernellis J; Androulakis AE; Mellas P; Kelepeshis GA; Gialafos JE
    Circulation; 1998 Apr; 97(14):1342-7. PubMed ID: 9577944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme.
    Eberli FR; Apstein CS; Ngoy S; Lorell BH
    Circ Res; 1992 May; 70(5):931-43. PubMed ID: 1314716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy.
    Dubois-Randé JL; Merlet P; Benvenuti C; Sediame S; Macquin-Mavier I; Chabrier E; Braquet P; Castaigne A; Adnot S
    Am J Cardiol; 1992 Oct; 70(9):906-12. PubMed ID: 1388329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy.
    Dubois-Randé JL; Merlet P; Duval-Moulin AM; Adnot S; Saal JP; Chabrier E; Castaigne A; Geschwind H
    Am Heart J; 1993 May; 125(5 Pt 1):1329-36. PubMed ID: 8480585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation.
    Bartunek J; Shah AM; Vanderheyden M; Paulus WJ
    Circulation; 1997 Jan; 95(1):90-6. PubMed ID: 8994422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function.
    Dubois-Rande JL; Adnot S; Benvenuti C; Merlet P; Hittinger L; Sediame S; Chabrier E; Braquet P; Castaigne A
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):608-14. PubMed ID: 1711628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
    Percy RF; Bass TA; Conetta DA; Miller AB
    Clin Cardiol; 1989 Aug; 12(8):435-40. PubMed ID: 2766589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide.
    Popma JJ; Smitherman TC; Bedotto JB; Eichhorn EJ; Said SI; Dehmer GJ
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):1000-6. PubMed ID: 1704974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and subacute hemodynamic effects of enalaprilat, milrinone and combination therapy in rats with chronic left ventricular dysfunction.
    Emmert SE; Stabilito II; Sweet CS
    Clin Exp Hypertens A; 1987; 9(2-3):297-306. PubMed ID: 3038390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.